MSCI has entered into a definitive agreement to sell its CFRA business, a provider of forensic accounting research, to a private investor for an undisclosed purchase price.

The transaction is expected to close within the next two months, subject to customary closing conditions.

CFRA is included within MSCI’s governance business segment for financial reporting purposes.

The transaction is not expected to have a material impact on MSCI’s results of operations.

Davis Polk & Wardwell acted as legal advisers to MSCI.